Bonner Michael 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Aug 31, 2018
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2018-08-28$5.92/sh+300$1,776→ 18,354 total - Purchase
Common Stock
2018-08-29$6.24/sh+100$624→ 18,454 total